Qiagen NV (Qiagen NV) Days Inventory

: 188.49 (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Qiagen NV's Average Total Inventories for the three months ended in Dec. 2023 was $399 Mil. Qiagen NV's Cost of Goods Sold for the three months ended in Dec. 2023 was $193 Mil. Hence, Qiagen NV's Days Inventory for the three months ended in Dec. 2023 was 188.49.

The historical rank and industry rank for Qiagen NV's Days Inventory or its related term are showing as below:

QGEN' s Days Inventory Range Over the Past 10 Years
Min: 99.08 Med: 116.5 Max: 192.41
Current: 192.41

During the past 13 years, Qiagen NV's highest Days Inventory was 192.41. The lowest was 99.08. And the median was 116.50.

QGEN's Days Inventory is ranked worse than
82.9% of 193 companies
in the Medical Diagnostics & Research industry
Industry Median: 65.4 vs QGEN: 192.41

Qiagen NV's Days Inventory increased from Dec. 2022 (172.28) to Dec. 2023 (188.49). It might indicate that Qiagen NV's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Qiagen NV's Inventory Turnover for the three months ended in Dec. 2023 was 0.48.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Qiagen NV's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.78.

Qiagen NV Days Inventory Historical Data

The historical data trend for Qiagen NV's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

116.83

132.20

140.99

165.27

188.67

Qiagen NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory																172.28	189.45	192.99	202.87	188.49

Competitive Comparison

For the Diagnostics & Research subindustry, Qiagen NV's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qiagen NV Days Inventory Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Days Inventory distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Days Inventory falls into.

Qiagen NV Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Qiagen NV's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (357.96	+	398.385)	/	2 )	/	731.623	*	365
=	378.1725					/	731.623	*	365
=	188.67

Qiagen NV's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (399.207	+	398.385)	/	2 )	/	193.062	*	365 / 4
=	398.796					/	193.062	*	365 / 4
=	188.49

Qiagen NV (NYSE:QGEN) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Qiagen NV's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	193.062	/	398.796
	=	0.48

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Qiagen NV's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	398.796	/	509.162
	=	0.78

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Qiagen NV Days Inventory Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (Qiagen NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Executives